Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia
- Resource Type
- Correspondence
- Source
- In
The Lancet 25 November-1 December 2017 390(10110):2343-2345 - Subject
Analysis and Interpretation Correspondence - Language
- ISSN
- 0140-6736